Medicine & Health

A team of wildlife biologists and infectious disease experts, including some at the School of Medicine, propose in an article published in Science a decentralized, global wildlife biosurveillance system to identify animal viruses that have the potential to cause human disease – before the next pandemic emerges.

Parasitologist L. David Sibley at the School of Medicine is leading an international effort to find drugs to cure toxoplasmosis, a parasitic disease characterized by vision problems and brain complications.

To help address the international social, economic and public health ramifications of the COVID-19 pandemic, the McDonnell International Scholars Academy recently awarded seed grants to kick-start research projects led by Washington University faculty members and their international collaborators.

The School of Medicine’s Jennifer A. Philips, MD, PhD, has set up a screening platform to test compounds for activity against the COVID-19 virus. Her lab has screened dozens of compounds and is prepared to accept more suggestions of promising candidate molecules.

The crowdsourced supercomputing project Folding@home, based at the School of Medicine, shifted focus months ago to coronavirus research. Now, units at Washington University and elsewhere, individuals and companies have joined the effort.

Over the years, the global HIV response has provided the modern medical community with valuable experience about responding to outbreaks and preventing the spread of the disease. These lessons should inform our approach to COVID-19 — especially in lower-income and Black communities, according to Shanti Parikh, associate professor of anthropology in Arts & Sciences at Washington University in St. Louis.

In the wake of the deaths of George Floyd, Rayshard Brooks and many more, a new study from the Brown School at Washington University in St. Louis finds that religion may offer a protective role for black adolescent boys who experience police abuse.

Faculty at the Washington University School of Medicine have joined an international effort led by the Foundation for Innovative New Diagnostics and the World Health Organization (WHO) to evaluate COVID-19 antibody tests for use as diagnostics in places with limited resources.

A combination of IV and oral antibiotics can effectively treat invasive infections in people who inject illicit drugs, according to a study from Washington University School of Medicine. The findings mean that patients can leave the hospital and complete taking their prescribed antibiotics at home.

School of Medicine physicians led efforts to create a repository for storing and managing specimens collected from patients with COVID-19. The samples are being distributed to investigators conducting COVID-19 research across the university.